Jonathan Paul Sleeman
Karlsruhe Institute of Technology · 273 works · 18,371 citations · h-index 59
Top works
- Complex networks orchestrate epithelial–mesenchymal transitions
- Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
- Oligosaccharides of Hyaluronan Activate Dendritic Cells via Toll-like Receptor 4
- Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression
- CD44 is required for two consecutive steps in HGF/c-Met signaling
- Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid
- CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis.
- An Essential Role for CD44 Variant Isoforms in Epidermal Langerhans Cell and Blood Dendritic Cell Function
- The Lymph Node as a Bridgehead in the Metastatic Dissemination of Tumors
- Markers for the lymphatic endothelium: In search of the holy grail?
- CD24 Expression Causes the Acquisition of Multiple Cellular Properties Associated with Tumor Growth and Metastasis
- Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer
- Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. John's wort that acts by induction of apoptosis
- Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity.
- Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats.
- Gene expression patterns associated with the metastatic phenotype in rodent and human tumors.
- CD44 Acts Both as a Growth‐ and Invasiveness‐Promoting Molecule and as a Tumor‐Suppressing Cofactor
- Tumor metastasis and the lymphatic vasculature
- Hyaluronate-independent metastatic behavior of CD44 variant-expressing pancreatic carcinoma cells.
- Cancer metastasis as a therapeutic target